15 terminated. 15 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Terminated 15 |
| Phase 2 | 3 | Terminated 3 |
Follow Dermatitis: new trials by email Literature Review of Dermatitis trials Research Report on Dermatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) Rocatinlimab, Placebo - Atopic Dermatitis | Phase 3 | Terminated | Amgen | 2621 | 2023-05-31 | 2026-07-16 |
| A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection etrasimod, Placebo - Atopic Dermatitis, Atopic Dermatitis, Unspecified | Phase 2 / Phase 3 | Terminated | Pfizer | 58 | 2023-01-18 | 2025-05-08 |
| Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis difelikefalin 0.25 mg, difelikefalin 0.5 mg, TCS Cream - Pruritus, Atopic Dermatitis | Phase 3 | Terminated | Cara Therapeutics, Inc. | 287 | 2022-08-16 | 2024-02-22 |
| Effects of Tralokinumab in the Skin: an Immunologic and Molecular Investigation Application of Tralokinumab - Atopic Dermatitis | Phase 2 / Phase 3 | Terminated | University of Zurich | 24 | 2022-06-15 | 2026-02-06 |
| A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis Crisaborole 2% - Atopic Dermatitis | Phase 3 | Terminated | Pfizer | 40 | 2020-09-14 | 2021-08-12 |
| Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2) Tradipitant, Placebo - Atopic Dermatitis | Phase 3 | Terminated | Vanda Pharmaceuticals | 87 | 2019-10-21 | 2024-05-14 |
| Efficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/Eczema Fucicort® Lipid cream, Fucidin® cream, Fucicort® Lipid cream vehicle - Infected Atopic Dermatitis/Eczema | Phase 3 | Terminated | LEO Pharma | 68 | 2018-07-31 | 2025-02-24 |
| A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis Baricitinib - Atopic Dermatitis | Phase 3 | Terminated | Eli Lilly and Company | 374 | 2018-06-27 | 2022-11-08 |
| Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch) 5 mg Serlopitant Tablets - Pruritus, Prurigo Nodularis | Phase 3 | Terminated | Vyne Therapeutics Inc. | 558 | 2018-03-15 | 2021-05-20 |
| Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis AIN457, Placebo - Non-infectious Uveitis | Phase 3 | Terminated | Novartis Pharmaceuticals | 86 | 2010-08-01 | 2016-01-14 |
| Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children Fluticasone, cream, Placebo, - Dermatitis, Atopic | Phase 3 | Terminated | Elena Rubio Gomis | 54 | 2009-12-01 | 2015-01-09 |
| Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer pyridoxine hydrochloride, Placebo - Dermatologic Complications, Palmar-plantar Erythrodysesthesia | Phase 3 | Terminated | National Cancer Centre, Singapore | 210 | 2007-06-01 | 2015-09-24 |
| Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer Capecitabine, Celecoxib, Radiation Therapy - Breast Cancer, Colorectal Cancer | Phase 3 | Terminated | M.D. Anderson Cancer Center | 11 | 2006-02-01 | 2015-12-24 |
| Lamictal in the Treatment of Post-Herpetic Neuralgia Lamictal in the treatment of Post-Herpetic Neuralgia - Neuralgia, Postherpetic | Phase 2 / Phase 3 | Terminated | George Washington University | 2005-02-01 | 2013-03-13 | |
| Atopic Dermatitis-Like Skin Disease in Pediatric Heart Transplant Patients Skin Biopsy - Dermatitis | Phase 3 | Terminated | Hordinsky, Maria K., MD | 30 | 2002-11-01 | 2013-02-05 |
Dermatitis, Atopic (9) · Eczema (7) · Hand-Foot Syndrome (2) · Pruritus (2) · Psoriasis (2) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Cardiovascular Diseases (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Drug-Related Side Effects and Adverse Reactions (1) · Myocardial Infarction (1) · Neuralgia, Postherpetic (1) · Pain (1)
Skin Diseases (15) · Skin and Connective Tissue Diseases (15) · Hypersensitivity (10) · Immune System Diseases (10) · Skin Diseases, Eczematous (10) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9) · Genetic Diseases, Inborn (9) · Hypersensitivity, Immediate (9) · Skin Diseases, Genetic (9) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (4) · Chemically-Induced Disorders (3) · Drug Eruptions (3) · Drug Hypersensitivity (3)
Betamethasone (1) · Capecitabine (1) · Celecoxib (1) · Fluticasone (1) · KHK4083 (1) · Lamotrigine (1) · Pyridoxine (1) · Radiotherapy (1) · baricitinib (1) · difelikefalin (1) · etrasimod (1) · secukinumab (1) · serlopitant (1)
Pfizer (2) · Amgen (1) · Cara Therapeutics, Inc. (1) · Elena Rubio Gomis (1) · Eli Lilly and Company (1) · George Washington University (1) · Hordinsky, Maria K., MD (1) · LEO Pharma (1) · M.D. Anderson Cancer Center (1) · National Cancer Centre, Singapore (1) · Novartis Pharmaceuticals (1) · University of Zurich (1) · Vanda Pharmaceuticals (1) · Vyne Therapeutics Inc. (1)
United States (10) · Canada (3) · Germany (3) · Poland (3) · Puerto Rico (3) · Spain (3) · Switzerland (3) · Austria (2) · Brazil (2) · China (2) · Czechia (2) · Israel (2) · Japan (2) · Singapore (2) · United Kingdom (2)
Elena Rubio Gomis, PhD MD (1) · Maria Hordinsky, MD (1) · Perry K. Richardson, M.D. (1) · Peter Schmid-Grendelmeier, Prof, MD (1) · Scott Kopetz, MD (1) · Yoon-Sim Yap, FRACP, MBBS (1)
PMID 28715540, PMID 33826132, PMID 36749121
2008 (1), 2009 (1), 2017 (1)